packageSemaglutide

semaglutide

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Semaglutide is a GLP-1 analogue medicine used to treat type 2 diabetes and obesity or overweight. It is widely used and authorised in the European Union, with products also studied for fatty liver disease and related liver conditions.

Summary written by glm-5.3-flash from Wikidata Q27261089 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:semaglutide
ATC codes:A10BJ06
DrugBank:DB13928
ChEBI:167574
Wikidata:Q27261089
molar mass:4114 g/mol (Drugs.Common 25.09, not verified)
logP:-5.8 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown